Showing results (111-120 of 125) with videos related to
Sort By:
Pageof 13
Radiology|April 16, 2011
Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CTDavid M Schuster, Bital Savir-Baruch, Peter T Nieh, et al.Biofabrication|April 10, 2025
Biofabrication of small-diameter vascular graft with acellular human amniotic membrane: a proof-of-concept study in pigO Aung, Peter J Rossi, Yingnan Zhai, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2020
A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid TumorsTaofeek K Owonikoko, R Donald Harvey, Bradley Carthon, et al.Brachytherapy|July 24, 2025
High-dose-rate (HDR) brachytherapy boost in combination with external beam radiotherapy for localized prostate cancer: An evidence-based consensus statementSagar A Patel, Marisa Kollmeier, Juanita Crook, et al.Brachytherapy|November 2, 2020
The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assuranceSteven J Frank, Firas Mourtada, Juanita Crook, et al.Journal of Vascular Surgery|November 26, 2025
The My PAD study for patient-reported outcomes for peripheral vascular intervention in the Vascular Quality InitiativeDaniel J Bertges, Matthew A Corriere, Jessica P Simons, et al.Journal of Vascular Surgery|November 20, 2019
Endovascular stenting of supra-aortic lesions using a transcarotid retrograde approach and flow reversal: A multicenter case seriesMark D Balceniuk, Maen Aboul Hosn, Robert S Corn, et al.Brachytherapy|August 21, 2021
Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancerVishal R Dhere, Benjamin W Fischer-Valuck, Subir Goyal, et al.Infection Control and Hospital Epidemiology|December 29, 2015
Preadmission Application of 2% Chlorhexidine Gluconate (CHG): Enhancing Patient Compliance While Maximizing Skin Surface ConcentrationsCharles E Edmiston, Candace J Krepel, Maureen P Spencer, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 20, 2016
Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CTOluwaseun A Odewole, Funmilayo I Tade, Peter T Nieh, et al.Pageof 13